Status:
NOT_YET_RECRUITING
Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation
Lead Sponsor:
Bedaya Hospital
Conditions:
Infertility
Eligibility:
FEMALE
35-44 years
Phase:
PHASE2
Brief Summary
The aim of this randomized controlled trial was to compare the efficacy and cost-effectiveness of using progestin with GnRH antagonist to prevent premature LH surge in poor responders undergoing doubl...
Eligibility Criteria
Inclusion
- Patients belonging to Poseidon group 4
Exclusion
- PCOS
- Endometriosis
- History of recurrent abortion
Key Trial Info
Start Date :
February 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06212102
Start Date
February 1 2024
End Date
December 1 2026
Last Update
January 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bedaya Hospital
Giza, Egypt